Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00879515 · ClinicalTrials.gov registry record
Examining Social, Emotional, and Cognitive Functioning in People With Fragile X and Down Syndromes
A clinical trial, sponsored by University of California, Davis.
- Completed
- Registry status
- 511
- Enrollment target
NCT00879515: Completed study, sponsored by University of California, Davis.
NCT00879515 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 511 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00879515 has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 511 participants
- Enrollment target
Study Summary
By testing physiological responses to anxiety in people with nervous system developmental disorders, this study will identify specific physiological characteristics associated with response to anxiety treatments.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 511 participants |
| Start Date | 2005-10 |
| Est. Completion | 2010-09 |
What the finished NCT00879515 record still lists
NCT00879515 is an observational study that tracks outcomes without assigning an intervention. The registered 511 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00879515 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00879515 about?
NCT00879515 is a clinical study titled "Examining Social, Emotional, and Cognitive Functioning in People With Fragile X and Down Syndromes". By testing physiological responses to anxiety in people with nervous system developmental disorders, this study will identify specific physiological characteristics associated with response to anxiety treatments.
What is the current status of trial NCT00879515?
This trial is currently completed. The enrollment target is 511 participants. The study started on 2005-10. Estimated completion is 2010-09.
Who is sponsoring clinical trial NCT00879515?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05005403 · 512 participants · Phase 1
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab
- NCT05337410 · 512 participants · NA
YES: Innovative Discussion for Engagement, Achievement, and Service
- NCT06096259 · 512 participants · Phase 2
Preventing Injured Knees From osteoArthritis: Severity Outcomes
- NCT03922542 · 510 participants · Phase 2
Comparison of Standard vs. Accelerated Corneal Crosslinking
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia